Comparing 2 spacers: blood levels of fluticasone and salmeterol; v1

• Research type

  Research Study

• Full title

  A randomised, open-label, four period, crossover study to assess the systemic exposure of fluticasone propionate from Flixotide™ 250 HFA pMDI and of fluticasone propionate and salmeterol from Seretide™ 250/25 HFA pMDI when given with the Ventolin® Mini-Spacer compared to the Aerochamber Plus® spacer in healthy subjects.

• IRAS ID

  143967

• Contact name

  Adeep Puri

• Contact email

  apuri@hmrlondon.com

• Sponsor organisation

  GlaxoSmithKline

• Eudract number

  2013-005023-16

• Clinicaltrials.gov Identifier

  NCT02045953

• REC name

  Scotland A REC

• REC reference

  13/SS/0219

• Date of REC Opinion

  23 Dec 2013

• REC opinion

  Further Information Favourable Opinion